Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
暂无分享,去创建一个
T. Pawlik | S. Curley | E. Abdalla | J. Vauthey | D. Nagorney | I. Ng | Y. Yamaoka | J. Belghiti | R. Poon | I. Ikai | G. Lauwers | J. Sarmiento
[1] J. Esteban,et al. Long interval between HCV infection and development of hepatocellular carcinoma. , 2008, Liver.
[2] H. Ishibashi,et al. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. , 2003, Hepato-gastroenterology.
[3] L. Ellis,et al. Comparison of Clinicopathologic Characteristics and Outcomes After Resection in Patients With Hepatocellular Carcinoma Treated in the United States, France, and Japan , 2003, Annals of surgery.
[4] L. Ellis,et al. Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas , 2002, Annals of surgery.
[5] L. Ellis,et al. Simplified staging for hepatocellular carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] T. Sodeyama,et al. [Global epidemiology of hepatocellular carcinoma]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[7] L. Ellis,et al. Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma , 2001, Journal of Gastrointestinal Surgery.
[8] L. Ellis,et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. , 2001, Archives of surgery.
[9] H. El‐Serag. Epidemiology of hepatocellular carcinoma. , 2001, Clinics in liver disease.
[10] Charles M. Miller,et al. Comparison of Surgical Outcomes for Hepatocellular Carcinoma in Patients With Hepatitis B Versus Hepatitis C: A Western Experience , 2000, Annals of Surgical Oncology.
[11] G. Chau,et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. , 2000, Surgery.
[12] H. Kinoshita,et al. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus–related hepatocellular carcinoma , 1999, Cancer.
[13] L. Dai,et al. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. , 1998, International journal of epidemiology.
[14] L. Jeng,et al. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma. , 1998, Surgery.
[15] N. Tanaka,et al. Direct detection of hepatitis B virus gene integrated in the Alexander cell using fluorescence in situ polymerase chain reaction. , 1997, Cancer Letters.
[16] N. Yamanaka,et al. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma , 1997, Cancer.
[17] M. Yu,et al. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non‐Asians in Los Angeles County, California , 1997 .
[18] M. Makuuchi,et al. Recurrence of hepatocellular carcinoma after surgery , 1996, The British journal of surgery.
[19] S. Kawasaki,et al. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirrhotic liver with hepatitis C , 1996, Hepatology.
[20] N. Tanaka,et al. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. , 1996, The American journal of gastroenterology.
[21] T. Kurata,et al. Hepatitis C and B virus infections in hepatocellular carcinoma: Analysis of direct detection of viral genome in paraffin embedded tissues , 1996, Cancer.
[22] K. Hasegawa,et al. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. , 1996, Hepatology.
[23] Y. Shiratori,et al. Characteristic difference of hepatocellular carcinoma between hepatitis B‐ and C‐ viral infection in Japan , 1995, Hepatology.
[24] K. Shirabe,et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C‐related hepatocellular carcinoma , 1995, Hepatology.
[25] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[26] N. Kinukawa,et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. , 1995, Gastroenterology.
[27] C. Bréchot,et al. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma , 1995, Hepatology.
[28] L. Sobin,et al. TNM supplement 1993. A commentary on uniform use , 1994 .
[29] R. Sallie,et al. Viral hepatitis and hepatocellular carcinoma. , 1994, Gastroenterology clinics of North America.
[30] C. Harris,et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Hoofnagle,et al. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B , 1993, Hepatology.
[32] T. Kasai,et al. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma , 1993, Cancer.
[33] Masakazu Yamamoto,et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular‐cholangiocarcinoma) in Japan , 1993, Cancer.
[34] K. Chayama,et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.
[35] Y. Nagafuchi,et al. Antihepatitis C virus status in hepatocellular carcinoma and the influence on clinicopathological findings and operative results , 1992, The British journal of surgery.
[36] Ding‐Shinn Chen,et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. , 1992, Gastroenterology.
[37] P. Scheuer,et al. Chronic hepatitis in multiple virus infection: histopathological evaluation , 1992, Histopathology.
[38] S. Sherlock,et al. The pathology of hepatitis C , 1992, Hepatology.
[39] Shinn-Jang Hwang,et al. The prevalence of anti‐hepatitis C virus among chinese patients with hepatocellular carcinoma , 1992, Cancer.
[40] S. Banks,et al. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B , 1991, Hepatology.
[41] M. Onji,et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[42] Lu-Yu Hwang,et al. HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.
[43] H. Edmondson,et al. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.
[44] E. Hatano,et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. , 2003, Surgical oncology clinics of North America.
[45] M. Makuuchi,et al. THE BRISBANE 2000 TERMINOLOGY OF LIVER ANATOMY AND RESECTION , 2002 .
[46] K. Griffiths,et al. Importance of field cancerisation in clinical oncology , 2000 .
[47] M. Makuuchi,et al. The Brisbane 2000 terminology of liver anatomy and resections. , 2000 .
[48] G. Fattovich,et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. , 1994, Cancer.
[49] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.
[50] J. Hoofnagle,et al. Viral hepatitis and liver disease , 1984 .